HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veikko Salomaa Selected Research

Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)

1/2016USF1 deficiency activates brown adipose tissue and improves cardiometabolic health.
1/2016The Contribution of GWAS Loci in Familial Dyslipidemias.
8/2009OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veikko Salomaa Research Topics

Disease

59Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 01/2002
35Coronary Disease (Coronary Heart Disease)
01/2024 - 02/2002
32Obesity
11/2022 - 12/2003
31Type 2 Diabetes Mellitus (MODY)
01/2023 - 02/2008
26Inflammation (Inflammations)
01/2023 - 10/2002
24Stroke (Strokes)
11/2023 - 08/2002
20Coronary Artery Disease (Coronary Atherosclerosis)
01/2023 - 02/2008
19Heart Failure
05/2024 - 01/2013
17Myocardial Infarction
04/2022 - 05/2008
15Hypertension (High Blood Pressure)
04/2024 - 03/2009
15Insulin Resistance
12/2019 - 02/2006
12Ischemic Stroke
12/2023 - 03/2005
12Liver Diseases (Liver Disease)
10/2023 - 05/2015
12Atrial Fibrillation
05/2023 - 01/2012
12Atherosclerosis
01/2019 - 12/2002
10Neoplasms (Cancer)
01/2023 - 02/2011
10Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2019 - 03/2007
8Acute Coronary Syndrome
12/2023 - 09/2005
8Dyslipidemias (Dyslipidemia)
11/2023 - 02/2006
7Genetic Risk Score
04/2024 - 11/2016
7Diabetes Mellitus
01/2023 - 06/2012
5Alzheimer Disease (Alzheimer's Disease)
01/2023 - 12/2016
5Dementia (Dementias)
01/2018 - 01/2015
5Tobacco Use Disorder (Nicotine Dependence)
01/2016 - 05/2010
4Glucose Intolerance
01/2021 - 06/2012
4Gout
10/2018 - 06/2009
3Chronic Obstructive Pulmonary Disease (COPD)
01/2023 - 01/2016
3Overweight
11/2022 - 01/2015
3Fatty Liver
11/2022 - 01/2017
3Lung Neoplasms (Lung Cancer)
11/2022 - 12/2013
3Chronic Renal Insufficiency
01/2022 - 10/2015
3Heart Diseases (Heart Disease)
12/2021 - 08/2012
3Endotoxemia
11/2021 - 02/2011
3Fibrosis (Cirrhosis)
06/2021 - 03/2011
3Infections
08/2020 - 04/2015
3Hemorrhage
01/2020 - 10/2014
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2020 - 01/2015
3Hypercholesterolemia
01/2020 - 04/2006
3Periodontitis
12/2019 - 07/2003
3Metabolic Diseases (Metabolic Disease)
12/2019 - 08/2014
3Asthma (Bronchial Asthma)
10/2018 - 10/2002
3Colorectal Neoplasms (Colorectal Cancer)
10/2017 - 01/2016
3Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)
01/2016 - 08/2009
3Heart Valve Diseases (Valvular Heart Disease)
08/2015 - 02/2013

Drug/Important Bio-Agent (IBA)

51LipidsIBA
01/2023 - 02/2010
43Biomarkers (Surrogate Marker)IBA
05/2024 - 06/2010
39CholesterolIBA
01/2023 - 12/2005
24HDL CholesterolIBA
11/2023 - 02/2008
22C-Reactive ProteinIBA
05/2024 - 10/2002
18Glucose (Dextrose)FDA LinkGeneric
01/2023 - 02/2006
16LDL CholesterolIBA
01/2023 - 02/2008
16Triglycerides (Triacylglycerol)IBA
01/2023 - 02/2008
15Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2010
14Lipoproteins (Lipoprotein)IBA
12/2021 - 09/2002
13Brain Natriuretic Peptide (Natrecor)FDA Link
05/2024 - 10/2011
13oxidized low density lipoproteinIBA
01/2023 - 02/2008
13Insulin (Novolin)FDA Link
01/2023 - 12/2002
13pro-brain natriuretic peptide (1-76)IBA
01/2023 - 05/2014
11Troponin IIBA
05/2024 - 09/2005
11HDL LipoproteinsIBA
01/2022 - 09/2002
10CytokinesIBA
01/2023 - 05/2009
7EnzymesIBA
11/2022 - 12/2002
7TroponinIBA
01/2020 - 09/2005
6Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2023 - 01/2006
6Glycoproteins (Glycoprotein)IBA
01/2021 - 12/2014
5Lipoprotein(a)IBA
01/2024 - 03/2005
5omega-Chloroacetophenone (Mace)IBA
04/2022 - 01/2014
5Antihypertensive Agents (Antihypertensives)IBA
04/2022 - 04/2006
5Natriuretic PeptidesIBA
11/2021 - 03/2009
5ApolipoproteinsIBA
06/2021 - 02/2006
5Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 04/2015
5AdiponectinIBA
09/2019 - 06/2011
4Hemoglobins (Hemoglobin)IBA
02/2024 - 12/2013
4Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2023 - 10/2010
4Vitamin DFDA LinkGeneric
03/2021 - 01/2013
4Amino AcidsFDA Link
12/2020 - 08/2014
4Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2020 - 05/2011
4LDL Lipoproteins (beta Lipoproteins)IBA
12/2019 - 02/2008
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2016 - 05/2010
4Fibrinogen (Factor I)FDA Link
10/2012 - 10/2002
3Troponin T (Troponin T1)IBA
05/2024 - 09/2005
3Interleukin-18 (Interleukin 18)IBA
11/2022 - 12/2008
3CreatinineIBA
01/2022 - 01/2018
3LipopolysaccharidesIBA
11/2021 - 04/2015
3Testosterone (Sustanon)FDA Link
01/2021 - 01/2018
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
12/2019 - 12/2014
3ORALIT (ORS)IBA
12/2019 - 04/2015
3EndotoxinsIBA
11/2019 - 06/2007
3InterleukinsIBA
01/2017 - 09/2008
3Apolipoproteins B (ApoB)IBA
12/2016 - 05/2011
3Hormones (Hormone)IBA
12/2016 - 01/2012
3Messenger RNA (mRNA)IBA
01/2016 - 02/2006
3Uric Acid (Urate)IBA
01/2015 - 06/2009
3AntibodiesIBA
12/2013 - 07/2003
3Hemostatics (Antihemorrhagics)IBA
07/2005 - 02/2002
2Bile Acids and Salts (Bile Acids)IBA
01/2024 - 09/2022
2Interferon-gamma (Interferon, gamma)IBA
01/2023 - 11/2022
2Isoleucine (L-Isoleucine)FDA Link
12/2022 - 01/2018

Therapy/Procedure

9Therapeutics
01/2023 - 03/2016
3Secondary Prevention
03/2016 - 12/2005